Logo for Pivotal Therapeutics Inc.
PVO

Pivotal Therapeutics Inc.

Statut
delisted
Émis et en Circulation96,566,669
Réservé pour Émission10,680,384
Devise
CSE Indice

À propos

Pivotal Therapeutics Inc.

Date d'inscription
19 mai 2011

Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® is available in the US by prescription only and OMAZEN™ is available for sale as a natural health product in Canada.The company's lead product VASCAZEN® is a prescription only Medical Food for the treatment of an Omega-3 Deficiency (OM3D) in patients with cardiovascular disease. The company's second product OMAZEN® is an ultra pure Omega-3 for the maintenance of good health.